{{Rsnum
|rsid=10488360
|Chromosome=7
|position=4371578
|Orientation=plus
|GMAF=0.3618
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 8.0 | 45.1 | 46.9
| HCB | 19.0 | 59.1 | 21.9
| JPT | 20.4 | 46.0 | 33.6
| YRI | 4.1 | 41.1 | 54.8
| ASW | 12.3 | 47.4 | 40.4
| CHB | 19.0 | 59.1 | 21.9
| CHD | 20.8 | 51.9 | 27.4
| GIH | 11.9 | 40.6 | 47.5
| LWK | 21.1 | 48.6 | 30.3
| MEX | 19.0 | 53.4 | 27.6
| MKK | 24.4 | 46.2 | 29.5
| TSI | 12.7 | 46.1 | 41.2
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs10488360
|PubMedID=17903294
|Condition=Factor VII
|Gene=Intergenic
|Risk Allele=
|pValue=7.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs10488360
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903294; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study (Initial Sample Size: 1,000 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Factor VII.
|Drugs=
|Drug Classes=
|Diseases=Hematologic Diseases
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356459
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10488360
|overall_frequency_n=47
|overall_frequency_d=128
|overall_frequency=0.367188
|n_genomes=35
|n_genomes_annotated=0
|n_haplomes=41
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}